Dyadic International Inc. is a biotechnology company pioneering the use of C1 gene expression platform to develop and produce enzymes and other proteins. With a strong focus on innovation and collaboration, the company is poised to disrupt the biomanufacturing industry and reshape the future of medicine and biofuels.
